Sensory Nociceptive Nerve Fibers, Key Regulator of Immune Response Type 2 in Atopic Dermatitis
NCT04193670 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2023-07-24
Summary
The skin is innervated by a network of nociceptive sensory neurons (nociceptors) whose primary function is the transmission of pain and pruritus signals to the central nervous system. Their role in atopic dermatitis (AD), characterized by an exacerbated type 2 immune response, is only partially understood. Nevertheless, large amounts of neuropeptides, including substance P (SP), are found in the serum of patients, their level being correlated with the clinical severity of AD. Mast cells (MC) are part of the cells of the immune system residing in the skin. MCs have neuro-receptors of the Mas-related G protein-coupled receptors family (MRGPR) and in particular MRGPRX2 (the receptor for cationic molecules \[including SP\] for MCs) through which they could communicate in a privileged way. with the nociceptors. Preliminary data obtained in mice show that its mouse orthologue "MrgprB2" is absolutely necessary for the development of type 2 immunity and the pathological characteristics of a preclinical "DA-like" model (manuscript in preparation). The investigators therefore hypothesize that the activation of MCs expressing MRGPRX2 by nociceptors producing SP plays a key role in the development of type 2 inflammation in AD in humans.
Conditions
Interventions
- OTHER
-
Clinical examination
This is a classic dermatological clinical examination during a classic consultation
- PROCEDURE
-
Biopsies
2 skin biopsies on a lesion area selected according to the inclusion criteria (2 punchs of 4 mm) for each experimental group. The first half of whole cutaneous biopsies (n = 25) will be studied using biphotonic microscopy. This will be performed on whole biopsies in 3-D according to the protocol developed in the laboratory. The second half of whole skin biopsies (n = 25) will be studied using the technique of single-cell RNA seq. The skin controls skin-free subjects will be obtained from skin reduction surgery (abdominoplasty) to subjects who have agreed to the use of their skin sample.
- OTHER
-
Blood test
A blood test on a tube (2 tubes of 10 mL).An assay of specific IgE and the serum level of IL-4, IL-13 and IL-5 will be carried out by ELISA (Enzyme Linked ImmunoSorbent Assay) from the blood samples.The blood samples will be obtained through the French blood establishment from different donors who have given their consent.
Sponsors & Collaborators
-
University Hospital, Toulouse
lead OTHER
Principal Investigators
-
Marie TAUBER · University Hospital, Toulouse
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-05-07
- Primary Completion
- 2022-02-03
- Completion
- 2022-12-31
Countries
- France
Study Locations
More Related Trials
-
Reference Values of Intraepidermal Nerve Fiber Density in Children and Small Fiber Neuropathy in Neurodevelopmental Disorders
NCT05645874 ·Status: COMPLETED
-
Response Profiles to High-concentration Capsaicin Desensitization in Patients with Peripheral Neuropathic Pain with or Without Allodynia: a Regional Multicenter Prospective Cohort
NCT05817591 ·Status: RECRUITING
-
A Study of the Effects of Topical Capsaicin in the Treatment of Provoked Vestibulodynia
NCT02854670 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
The Effect of Ablation of Epidermal Nerve Fibers Using Capsaicin Cream
NCT01883102 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain
NCT00034710 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness and Safety of Implantable Intrathecal Systems for Refractory Pain in Spain (INTRATHECAL-RENASED)
NCT05970081 ·Status: UNKNOWN
-
Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis
NCT02174419 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Testing Protocol to Efficiently Induce Itch
NCT05195177 ·Status: UNKNOWN ·Phase: NA
-
Topographical Distribution of Itch and Pain Receptors
NCT07122973 ·Status: RECRUITING ·Phase: NA
-
NS1209 and Lidocaine in Patients With Peripheral Neuropathic Pain
NCT00258622 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Efficacy and Safety of DWP05195 in Subjects With Post-Herpetic Neuralgia
NCT01557010 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Laser Speckle Contrast Imaging to Assess Changes in Chemical Agent-Induced Skin Blood Flow in Healthy Participants (MK-0000-420)
NCT06809569 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy
NCT02574962 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effects of High-concentration Topical Capsaicin on Histaminergic and Non-histaminergic Itch
NCT02769910 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparative Study in Patients With Refractory Chronic Lower Limb Neuropathic Pain and/or Back Neuropathic Pain.
NCT04852107 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy of FSD201 for the Treatment of Chronic Pain Associated With Idiopathic MCAS (MCAD)
NCT05652907 ·Status: TERMINATED ·Phase: PHASE2
-
IVIG in Painful Sensory Neuropathy
NCT06183008 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Autofluorescent Flavoprotein Imaging of Intraepidermal Nerve Fibers: a Pilot Study
NCT02537951 ·Status: COMPLETED ·Phase: NA
-
A Human Experimental Model for Neuropathic Pain Using Combined Application of Capsaicin and Local Anesthetics
NCT01540877 ·Status: COMPLETED ·Phase: NA
-
DOLORisk: Research on Risk Factors and Determinants for Neuropathic Pain
NCT04888455 ·Status: COMPLETED
-
Capsaicin Nanoparticle in Patient With Painful Diabetic Neuropathy
NCT01125215 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Efficacy Study of Botox to Treat Neuropathic Pain
NCT00527202 ·Status: COMPLETED ·Phase: PHASE4
-
The Role of TRP Channels in CIPN
NCT04415892 ·Status: RECRUITING ·Phase: NA
-
An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain
NCT00089557 ·Status: TERMINATED ·Phase: PHASE2
-
NPC-06 to Acute Pain in Herpes Zoster
NCT04139330 ·Status: TERMINATED ·Phase: PHASE2